Guangzhou Xiangxue Pharmaceutical Co., Ltd.
http://www.xphcn.com/index.aspx
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Guangzhou Xiangxue Pharmaceutical Co., Ltd.
Finance Watch: Regulus Shrinks To Preserve Cash, Ironwood Cuts Jobs Ahead Of Split
Public Company Edition: Long-struggling Regulus is laying off employees and pausing its two clinical programs. Also, Ironwood is shuffling staff ahead of splitting into two companies and will cut 40 jobs in the process. And among several loan agreements and note sales, Tesaro borrows another $200m.
Medtech Execs On The Move, September 2013
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Deals Shaping The Medical Industry, December 2012
Derived from Strategic Transactions, EBI’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals– and then categorized by type –Acquisition, Alliance, or Financing.
Medical Device Deals Update, November-December 2012
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
Company Information
- Industry
- Distributors
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Xiangxue Pharmaceuticals, Co., Ltd
- Xiangxue Life Sciences
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice